Pre-Eclampsia Control
Pre-Eclampsia Control
The Pre-eclampsia Control is intended for use with in vitro diagnostic assays for the quantitative determination of placental growth factor (PlGF) and soluble fms‑like tyrosine kinase‑1 (sFlt-1) in human serum and plasma.
The Pre-eclampsia Control is assayed with target values and is suitable for use on various immunoassay analysers. The Pre-eclampsia Control is for use by trained laboratory professionals and can be used in determining the precision of testing systems and in identifying sources of variation.
Features & Benefits
- – Liquid frozen for user convenience
- – Human based serum ensuring a commutable sample matrix
- – 30 days open vial stability when stored at 2ºC to 8ºC keeping waste and costs to a minimum
- – True third party control providing an unbiased assessment of performance
- – Assayed target values provided
Analytes
- – sFlt-1
- – PIGF
Active Vitamin B12 Quality Control
The Randox Acusera Active Vitamin B12 Control is designed to deliver a cost-effective, high quality solution for use in the quantitative determination of Active Vitamin B12 in human serum and plasma.
The human serum based Active B12 Controls are assayed with target values provided and are suitable for use on various analysers.
Features & Benefits
- Liquid frozen for user convenience
- Human based serum ensuring a commutable sample matrix
- True Third Party control providing unbiased assessment of performance
- An impressive open vial stability of 30 days at 2° to 8°C helping to keep waste to a minimum
Analytes
- Active Vitamin B12 (Holotranscobalamin/HoloTC)
Bone Markers (Serum) Control
The Lyophilised Serum Bone Marker Control is intended for use with in vitro diagnostic assays for the quantitative determination of Procollagen Type 1 N-Terminal Propeptide (P1NP), N-MID Osteocalcin (OC) and Bone Alkaline Phosphatase (B-ALP) in serum samples.
This Lyophilised Serum Bone Marker Control is assayed with target values and is suitable for use on automated analysers.
Features & Benefits
- – Lyophilised for enhanced stability
- – True third party control providing an unbiased assessment of performance
- – Three clinically relevant levels available
- – Human based serum providing a matrix similar to the patient sample
- – 1 year shelf life from date of manufacture allowing for long term QC monitoring and a decrease in new lot validation studies
- – 14- day reconstituted open vial stability applies for PINP and B-ALP helping to keep waste to a minimum, 1-day reconstituted stability for N-MID Osteocalcin
Analytes
- – PINP
- – N-MID Osteocalcin
- – Bone-ALP
*No claims are made regarding values and stability.
Xanthochromia Quality Control
The Randox Acusera Xanthochromia Control is designed to deliver a cost-effective, true third party solution for use in monitoring the performance of Bilirubin and Oxyhaemoglobin in Cerebrospinal Fluid (CSF) using a spectrophotometer.
Aqueous based with components of human origin, the Xanthochromia Controls are unassayed and are suitable for use with various UV spectrophotometers.
Supplied in a liquid frozen format, this control should be treated in the same manner as a patient sample.
Features & Benefits
- Liquid frozen format for convenience and reduced handling errors
- Aqueous based with components of human origin
- True Third Party control providing unbiased assessment of performance
- An Open Vial stability of 2 days at 2° to 8°C. Stable for 11 weeks when stored unopened at -18° to -24°C helping to keep waste to a minimum.
Analytes
- Billirubin
- Oxyhaemoglobin
*No claims are made regarding values and stability.
Product Focus: Latest RIQAS Programmes
RIQAS is the largest international External Quality Assessment (EQA)/ Proficiency Testing (PT) scheme, with over 45,000 participants across 32 comprehensive programme options. Providing access to large, international peer groups you can be confident in the statistical validity of the results obtained.
In March 2016, we added eight new RIQAS EQA programmes to our already extensive portfolio. The new programmes included; CSF, Sweat Testing, Immunosuppressant drugs, Trace Elements in Serum, Trace Elements in Urine, Trace Elements in Blood, Anti-TSH Receptor (TRAb) and Cyfra 21-1.
Like all programmes the latest additions are designed to cover the full clinical decision range, reassuring clinicians and patients that the results released are accurate and reliable. The added benefit of monthly reporting supports the rapid identification of errors, this combined with a report turnaround of 24-72 hours from the submission deadline allows faster implementation of any necessary corrective actions, reducing the need for expensive and time consuming patient sample retests.
With Cycle 2 of the new programmes just around the corner we thought we would take this opportunity to explore what each programme has to offer.
Week 1- Trace Elements in Serum, Trace Elements in Urine, Trace Elements in Blood
RIQAS provide three trace element programmes designed for use in clinical and toxicology laboratories specialising in the testing of trace metals, heavy metals and minerals. Options are available for blood, serum and urine ensuring a matrix similar to that of the patient sample. Each programme will help ensure the accuracy of test results in patients who have experienced accidental or occupational exposure to such toxic metals
Main Features and Benefits;
- Lyophilised samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
Week 2- CYFRA 21-1 & Anti-TSH Receptor
The RIQAS CYFRA 21-1 EQA programme is designed to cover the analysis of the tumour marker CYFRA 21-1 in clinical laboratories when monitoring the response to treatment of cancers such as non-small cell lung carcinoma, cervical, breast and bladder cancer.
Main Features and Benefits;
- Lyophilised samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
Our dedicated Anti-TSH Receptor EQA programme is designed to supplement our general immunoassay programme by including the thyroid hormone Anti-TSH Receptor also known as TRAb.
Main Features and Benefits;
- Lyophilised samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
Week 3 – CSF & Sweat Testing
The RIQAS Cerebrospinal Fluid EQA programme has been designed to monitor the performance of several analytes in CSF.
Main Features and Benefits;
- Liquid ready-to-use samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
The RIQAS Sweat Testing EQA programme has been designed to cover the analysis of Sweat Testing in clinical laboratories measuring the concentration of Chloride, Sodium and Conductivity in sweat, used in the testing of Cystic Fibrosis (CF).
Main Features and Benefits;
- Liquid ready-to-use samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
Week 4 – RIQAS Immunosuppressant EQA programme
The RIQAS Immunosuppressant Drug EQA programme has been designed to cover the analysis of Cyclosporin, Everolimus, Sirolimus and Tacrolimus in clinical laboratories.
Main Features and Benefits;
- Lyophilised samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
- Submit results and view reports online via RIQAS.net
- 12 month subscription
Liquid CSF Quality Control
Providing a true third party solution for the measurement of Cerebrospinal Fluid (CSF), the Acusera Liquid CSF Control is designed to deliver an unbiased, independent assessment of analytical performance for 14 analytes, helping to ensure the results clinical laboratories release are accurate and reliable.
With an extended open vial stability of 30 days at 2oC – 8oC, the Acusera Liquid CSF Control will reduce waste, while remaining easy and convenient to use.
Features & Benefits
- Liquid ready-to-use samples requiring no preparation
- Human based material
- True third party control providing unbiased performance assessment
- Assayed target values available
- Shelf life of 2 years from the date of manufacture
- Open vial stability of 30 days for all analytes when stored at 2oC to 8oC
| Description | Size | Analytes | Cat No | |
|---|---|---|---|---|
| Liquid CSF Control Level 1 | 10 x 3ml | 14 | CF10138 | |
| Liquid CSF Control Level 2 | 10 x 3ml | 14 | CF10139 | |
Analytes
- Albumin
- Albumin (electrophoresis)*
- Alpha – 1- globulin (electrophoresis)*
- Alpha – 2- globulin (electrophoresis)*
- Beta- globulin (electrophoresis)*
- Chloride
- Gamma – globulin (electrophoresis)*
- Glucose
- hsIgA*
- hsIgG
- hsIgM*
- Lactate
- Protein (Total)
- Sodium
*No claims are made regarding values and stability.
CSF Quality Control
The Randox Acusera cerebrospinal fluid quality control is designed for use in the routine monitoring of both accuracy and precision on a wide range of instruments. Assayed method specific target values and ranges are provided for 11 parameters including percentage total protein quoted for electrophoresis regions at Albumin, Alpha-1-Globulin, Alpha-2-Globulin, Beta Globulin and Gamma Globulin.
Features & Benefits
- Lyophilised for enhanced stability
- Human based material
- Assayed target values provided for 11 parameters
- Stable to expiry date at 2°C – 8°C
- Reconstituted stability of 14 days at 2°C – 8°C
| Description | Size | Analytes | Cat No | |
|---|---|---|---|---|
| CSF Control Level 2 | 10 x 3ml | 11 | CF1500 | |
| CSF Control Level 3 | 10 x 3ml | 11 | CF1501 | |
Analytes
- Albumin (electrophoresis)*
- Alpha – 1- globulin (electrophoresis)*
- Alpha – 2- globulin (electrophoresis)*
- Beta- globulin (electrophoresis)*
- Chloride
- Gamma – globulin (electrophoresis)*
- Glucose
- Immunoglobulin G (IgG)
- Lactate
- Protein (Total)
- Sodium
*No claims are made regarding values or stability